Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

68results about How to "Reduce calcification" patented technology

Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction

Methods for decellularizing mammalian tissue for use in transplantation and tissue engineering. The invention includes methods for simultaneous application of an ionic detergent and a nonionic detergent for a long time period, which may exceed five days. One method utilizes SDS as the ionic detergent and Triton-X 100 as the nonionic detergent. A long rinse step follows, which may also exceed five days in length. This long duration, simultaneous extraction with two detergents produced tissue showing stress-strain curves and DSC data similar to that of fresh, unprocessed tissue. The processed tissue is largely devoid of cells, has the underlying structure essentially intact, and also shows a significantly improved inflammatory response relative to fresh tissue, even without glutaraldehyde fixation. Significantly reduced in situ calcification has also been demonstrated relative to glutaraldehyde fixed tissue. Applicants believe the ionic and non-ionic detergents may act synergistically to bind protein to the ionic detergent and may remove an ionic detergent-protein complex from the tissue using the non-ionic detergent. The present methods find one exemplary use in decellularizing porcine heart valve leaflet and wall tissue for use in transplantation.
Owner:UEDA YUICHIRO +1

Polyphenol cross-linking agent and application thereof to preparation of anti-calcification biovalve

The invention relates to a polyphenol cross-linking agent and application thereof to preparation of an anti-calcification biovalve. The polyphenol cross-linking agent is prepared in a way that polyphenol compound is dissolved in organic solvent, and then, buffer solution is adopted for dilution, wherein the polyphenol compound is selected from one or multiple of procyanidine, curcumin, resveratrol, puerarin, aloin and aloe-emodin. The preparation method for the anti-calcification biovalve comprises the following steps: dipping a bio-based material which completely removes cells into the polyphenol cross-linking agent to be subjected to cross-linking, and fully cleaning after ending; dipping in PBS (polybutylene succinate) solution and / or D-Hanks solution to be subjected to post-processingto obtain the anti-calcification biovalve. The anti-calcification biovalve provided by the invention has better mechanical property and stability, tissue calcification, inflammation and thrombus can be obviously reduced, biotoxicity is lowered, service life is greatly prolonged, and the defects of serious calcification, short service life and the like of biological cardiac valve materials processed with a traditional glutaraldehyde crosslinking method are overcome.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Invisible fish blockage control system based on network structure

The invention discloses an invisible fish blockage control system based on a network structure. The invisible fish blockage control system comprises a master controller and a plurality of node controllers for controlling fish blockage, wherein the master controller is connected with each node controller through a controller area network (CAN) bus and monitors the operating states of the node controllers; the master controller comprises a master microprocessor, an operation and display processing module and a switching power supply module; the operation and display processing module is connected with the master microprocessor and selects the node controller through the master microprocessor and displays the operating state of the node controller; and the switching power supply module is connected with the master microprocessor, receives the control of the master microprocessor and supplies power to the node controller. According to the control system, multiple fish blockage equipment can be monitored in a unified mode, and the fish blockage out-of-control time is reduced; and moreover, the invisible fish blockage control system has the capacity of automatically adapting to various water areas, good fish blockage effect, long-term free maintenance and the capacity of continuously working all the year round.
Owner:CHONGQING GENSEN ELECTRONICS SCI & TECH CO LTD

Dry artificial biological heart valve containing polypeptide for promoting endothelialization and preparation method of dry artificial biological heart valve

The invention discloses a dry artificial biological heart valve containing polypeptide for promoting endothelialization and a preparation method of the dry artificial biological heart valve. The method comprises the following steps that cross-linking is performed on amino groups and carboxyl groups of an animal pericardium, and endothelialization treatment, hydrogel polymerization treatment and dewatering and drying treatment are performed on the animal pericardium, wherein the endothelialization treatment involves that the polypeptide for promoting the endothelialization is adopted to treat the animal pericardium. The preparation method has the advantages that the prepared dry biological heart valve has good water immersion flattening performance, and can be quickly immersed in water andflattened at a higher temperature and higher humidity, thereby reducing residues of glutaraldehyde and the like, and reducing the problems of calcification and toxicity which are caused by the glutaraldehyde and the like, therefore the preoperative installation of a valve system can be simplified, and the additional risks of surgeries are reduced; the polypeptide capable of promoting the endothelialization is also added in the preparation process, so that the prepared biological valve has the property of promoting the endothelialization.
Owner:JILIN VENUS HAOYUE MEDICAL LTD

Bioprosthetic tissue preparation with synthetic hydrogels

Methods for treating xenogenic tissue for implantation into a human body including in-situ polymerization of a hydrogel polymer in tissue, and tissue treated according to those methods, where the polymerization takes place in tissue that has not been fixed with glutaraldehyde. The polymerization may only fill the tissue, bind the polymer to the tissue, or cross-link the tissue through the polymer, depending on the embodiment. One method includes free radical polymerization of a first vinylic compound, and can include cross-linking through use of a second compound having at least two vinyl groups. Another method utilizes nucleophilic addition polymerization of two compounds, one of which can include PEG and can further include hydrolytically degradable regions. In one embodiment, applicants believe the in-situ polymerization inhibits calcification, and that the polymerization of tissue un-fixed by glutaraldehyde allows for improved penetration of the polymer. The methods find one use in the treatment of porcine heart valve tissue, intended to extend the useful life of the valves by inhibiting calcification. The incorporation of degradable hydrogel regions may initially fill the tissue and reduce any initial inflammatory response, but allow for later infiltration by cells to remodel the tissue.
Owner:MEDTRONIC INC

Anaerobic membrane bioreactor for effectively treating kitchen waste water and treatment method using the same

The invention discloses an anaerobic membrane bioreactor for effectively treating kitchen waste water and a treatment method using the same. The anaerobic membrane bioreactor orderly comprises an anaerobic tank, a circulating pump, a water inlet pump, a water inlet tank and a water outlet tank from left to right. The circulating pump and the water inlet pump are respectively connected to the anaerobic tank. The water inlet tank is connected to the water inlet pump. The treatment method comprises adding sludge into the anaerobic membrane bioreactor, setting different sludge staying time, mixing kitchen waste water and a film concentrated solution, feeding the mixture into an anaerobic jar through a water distribution pipe, discharging the decomposing biogas through a water-sealed tank, feeding undecomposed mixed solution into the circulating pump and a membrane module, mixing the undecomposed mixed solution and kitchen waste water fed by the water inlet pump, feeding the mixed solution into the anaerobic jar through a water distribution pipe, and carrying out circulation. The bioreactor and method can eliminate accumulation of colloidal state and dissolved macromolecule organic matters through reasonable control of the sludge residence time, reduce a Ca<2+> accumulation concentration, and reduces a degree of calcification of the sludge. The anaerobic membrane bioreactor has optimal effects of treating kitchen waste water.
Owner:SUZHOU KANGDUN ENVIRONMENTAL PROTECTION TECH CO LTD

Application of carbonic anhydrase inhibitor to preparation of anti-atherosclerosis drugs

The invention belongs to the field of anti-arteriosclerosis drugs, and particularly relates to application of a carbonic anhydrase inhibitor to preparation of the anti-arteriosclerosis drugs. The study finds for the first time that carbonic anhydrase 1 (CA1) is highly expressed in arteriosclerosis calcified tissue, and CA1 is related to vascular smooth muscle calcification and affects cell proliferation and apoptosis. Methazolamide, the inhibitor of CA1, can significantly reduce the progression of atherosclerosis and inhibit atherosclerotic inflammatory factors. The results suggest that calcification plays an important role in atherosclerosis, and CA1-dominated calcification promotes the course of the atherosclerosis. Methazolamide has a potential therapeutic effect on the atherosclerosisby inhibiting expression of CA1. The findings not only further explain the close relationship between the atherosclerosis and the calcification, but also explore the calcification mechanism of the atherosclerosis, and further prove that inhibition of the calcification is a key point in the treatment of the atherosclerosis. The application of the carbonic anhydrase inhibitor to the preparation of the anti-arteriosclerosis drugs provides new ideas for the treatment of the atherosclerosis.
Owner:青岛汇嘉医学科技有限公司

Valve with anti-thrombosis and anti-calcification functions, and preparation method and application of valve

The present invention discloses a valve with anti-thrombosis and anti-calcification functions, and a preparation method and an application of the valve. The valve comprises a valve base and a zwitterionic copolymer covalently connected to the valve base. During preparation, the valve base is firstly soaked in a glutaraldehyde solution to obtain a cross-linked valve; and then the cross-linked valveis soaked in a zwitterionic polymer solution with a concentration of 0.1-5 wt% for reaction for 2-4 days, and then reduction with a reducing agent is conducted to obtain the valve with the anti-thrombosis and anti-calcification functions. The valve material is subjected to anti-thrombosis and anti-calcification treatments, so that after the valve is implanted in patients, risks of valve leaflet thrombosis can be reduced, valve leaflet thickening and transvalvular differential pressure increase are prevented, a long-term hydrodynamic performance is improved, patients can avoid or reduce uses of anticoagulant and antiplatelet drugs, risks of patient bleeding are reduced, besides, aldehyde residues in the valve leaflet tissues are reduced, biocompatibility and anti-calcification ability areimproved, and ultimately complications of valve leaflet thrombosis are reduced and service life of the valve is extended.
Owner:JILIN VENUS HAOYUE MEDICAL LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products